People · Operator
Named in public records as an officer, director or promoter · active 2021–2023 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Asylia Therapeutics, Inc. | — | Biotechnology | Series A | $8.2M | $218.8M | 2021 |
| VidaFuel, Inc. | — | Other | Seed | $6.3M | $13.0M | 2023 |
JOSEPH KEKST at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside JOSEPH KEKST on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| KERRY RUPP | 1 | 4 |
| Robert Pflieger | 1 | 2 |
| Andy Ambrose | 1 | 2 |
| Michael Glick | 1 | 2 |
| Elan Ezickson | 1 | 2 |
| Jeno Gyuris | 1 | 2 |
| Bette Parolini | 1 | 1 |
| Elana Gold | 1 | 1 |
| STEVEN SPINNER | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.